reviewCurrent Opinion in OncologyNov 28, 2012Closed access

TGF-β signaling and epithelial–mesenchymal transition in cancer progression

University of California, San Francisco · University of California San Francisco Medical Center · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

PURPOSE OF REVIEW: TGF-β acts as a potent driver of cancer progression through the induction of epithelial-mesenchymal transition (EMT), in which epithelial cells acquire mesenchymal phenotype, leading to enhanced motility and invasion. Recent reports highlight the fundamental roles of TGF-β-induced EMT in multiple aspects of cancer progression. In this review, we focus on the novel insights into the roles of TGF-β-induced EMT in cancer progression and the underlying mechanisms that enable TGF-β to activate this epithelial plasticity response at transcription, translation, and posttranslational levels. RECENT FINDINGS: Smad-mediated transcription regulation is known to activate TGF-β-induced EMT. More…

Citation impact

783
total citations
FWCI
26.75
Percentile
100%
References
75
Citations per year

Authors

3

Topics & keywords

Keywords
  • Epithelial–mesenchymal transition
  • Cancer research
  • Cancer cell
  • Stromal cell
  • Cancer
  • Tumor progression
  • Epigenetics
  • SMAD
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.